In order to determine whether MGCP is protective against a second model of experimental autoimmune disease, we applied MGCP to mice immunized with MOG35–55 peptide to induce experimental autoimmune encephalomyelitis (EAE). Here, FOLH1 is linked to experimental autoimmune encephalomyelitis.